title: Development of multiple myeloma in a patient with chronic myeloid leukemia after treatment with imatinib mesylate.
authors.forename: Vassilia
authors.initials: V
authors.lastname: Garipidou
authors.forename: Sofia
authors.initials: S
authors.lastname: Vakalopoulou
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Tziomalos
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001549:Benzamides; D018450:Disease Progression; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D009101:Multiple Myeloma / Q000139:chemically induced*; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate